Search results
'Yeh Rishta Kya Kehlata Hai' actor Hina Khan diagnosed with stage 3 breast cancer, says, "I am...
Business Insider India· 14 hours ago' actor shared that she has started treatment and is "doing well" and "fully committed" to...
Alzheimer’s disease: Preventive measures and lifestyle changes for managing symptoms
CNBC Awaaz· 17 hours agoAlzheimer's disease is a progressive neurological condition that impacts memory and cognitive...
Enhancing Cancer Treatment: Pharmacogenomics Impact on Drug Response and Toxicity
SiliconIndia· 2 hours agoMithun Kumar K B, Correspondent, siliconindiaPharmacogenomics has introduced a major change in the management of cancer because the genetic constitution of patients and their ...
Ankle Rash Causes and Treatments
Verywell Health· 3 days agoThe rash may be limited to your ankles or affect other parts of your body. ...bumps that form in clusters. However, the rash color can vary based on skin...
Hina Khan reveals stage 3 breast cancer diagnosis, begins treatment: 'I am strong and committed'
Indiatimes· 16 hours agoTV actress Hina Khan, known for her Yeh Rishta Kya Kehlata Hai role, has been diagnosed with stage 3...
Parkinson's disease symptoms: Muscle rigidity, tremors, postural instability
CNBC Awaaz· 13 hours agoParkinson's disease is a neurological condition that worsens over time and mostly affects mobility....
Hina Khan Breast Cancer Diagnosis: What Is The Survival Rate Of Breast Cancer Stage 3? All You Need...
Filmibeat· 16 hours agoHina Khan Breast Cancer Diagnosis: Best known for her role in Yeh Rishta Kya Kehlata Hai, TV star...
Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Pharmaceutical Technology· 13 hours agoEisai and Biogen have announced the introduction of LEQEMBI (lecanemab) for the treatment of...
Uses of precision medicine in healthcare
Medical Device Network· 10 hours agoand enabled researchers to identify genetic variations linked to specific diseases. Subsequent technological advancements such as next-generation...
Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran
Pharmaceutical Technology· 4 days agoRandomisation was stratified based on the patients’ use of Pfizer’s Vyndaqel/Vyndamax (tafamidis)—an...
